Clinical trial
Eversense® Non-adjunctive Use Post Approval Study
NCT04836546
Study timeline
Study start (actual)2021-04-13Date precision: day
Registry last updated2025-08-13
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetesunresolved
Interventions
Blood glucose meterDEVICE
Eversense CGM SystemDEVICE
Sponsors & collaborators
Senseonics, Inc.lead sponsor
Mapped research locations
HoustonTexas, United States1Los AngelesCalifornia, United States1DallasTexas, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1AustinTexas, United States1Fort LauderdaleFlorida, United States1SpringfieldIllinois, United States1GreenvilleNorth Carolina, United States1WaterburyConnecticut, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04836546 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.